Health
Chronicle Pharmabiz
Panel recommends DoP to study on difference between PTS, MRP
THE Parliamentary Panel on Chemicals and Fertilisers has recommended to the Department of Pharmaceutical (DOP) to conduct a study on the significant difference between the Price to Stockist (PTS) and Maximum Retail Price (MRP) printed on the medicine, and the reasons.
2 min |
November 20, 2025
Chronicle Pharmabiz
Lupin launches risperidone with 180-day CGT exclusivity
GLOBAL pharma major Lupin the launch of risperidone for extended-release injectable suspension, 25 mg per vial, 37.5 mg per vial, and 50 mg per vial, single-dose vials, with 180-day CGT exclusivity in the US.
1 min |
November 20, 2025
Chronicle Pharmabiz
Karnataka pharma in compliance mode for revised Schedule M
THE Karnataka pharmaceutical industry has worked diligently to comply with the revised Schedule M of the Drugs Rules, which governs the manufacturing and quality control of drugs.
2 min |
November 20, 2025
Chronicle Pharmabiz
CDSCO alerts on toxic syrup; Haryana to expand quality vigil
A critical public health alert has been issued following the detection of a toxic impurity, diethylene glycol (DEG), in a batch of cough syrup, triggering immediate and stringent regulatory action across India, particularly in Haryana.
2 min |
November 20, 2025
Chronicle Pharmabiz
PCI directs Councils to submit pharmacists' data by Nov 30
THE Pharmacy Council of India (PCI) has directed all the State Pharmacy Councils to submit the data of registered pharmacists in their States in a stipulated format on immediate basis by November 30, 2025, in order to facilitate National Health Authority (NHA) to create a consolidated data on pharmacists in the country under the Health Professional Registry (HPR).
2 min |
November 20, 2025
Chronicle Pharmabiz
India sets global benchmark in rabies prophylaxis through RmAbs
NDIA leads the world in advanced rabies prophylaxis by manufacturing Rabies Monoclonal Antibodies (RmAbs), including WHO-collaborated Cocktail RmAbs.
1 min |
November 20, 2025
Chronicle Pharmabiz
Odisha govt convenes 'Pharma summit' on Nov 20 in Bhubaneswar
THE Government of Odisha has issued a comprehensive and robust invitation to investors from across the country to participate in the upcoming 'Odisha Pharma Summit' scheduled for November 20 in Bhubaneswar.
2 min |
November 13, 2025
Chronicle Pharmabiz
APPC announces election schedule to elect 6-member
THE office of the returning officer (RO) for the election of the Andhra Pradesh Pharmacy Council (APPC) has issued an official notice, dated November 2, 2025, detailing the schedule for the election of six members to the council.
1 min |
November 13, 2025
Chronicle Pharmabiz
NPPA fixes revised prices of 6 scheduled formulations
THE National Pharmaceutical Pricing Authority has fixed the ceiling price of six formulations under the revised Schedule I of DPCO 2013, including three strengths of human immunoglobulin, denatured ethyl alcohol, peritoneal dialysis solution, and vitamin tablet riboflavin.
1 min |
November 13, 2025
Chronicle Pharmabiz
WHO launches guidance for health emergencies
THE World Health Organization (WHO) has released a comprehensive guide, the National Health Emergency Alert and Response Framework, to help countries strengthen their preparedness and response to health emergencies.
1 min |
November 13, 2025
Chronicle Pharmabiz
AI, next-gen diagnostics offer new hope in India's cancer battle
HOSPITALS and pharma industry note that in India's battle against cancer, biomarkers, nextgen sequencing diagnostics and Al-based tools empower clinicians to identify risks earlier.
2 min |
November 13, 2025
Chronicle Pharmabiz
UK MHRA approves Serum Life Sciences' Siiltibcy
THE Medicines and Healthcare products Regulatory Agency (MHRA) has approved Siiltibcy (rdESAT-6 and rCFP-10), a diagnostic aid for detection of Mycobacterium tuberculosis infection, including tuberculosis disease, in adults and children.
1 min |
November 13, 2025
Chronicle Pharmabiz
Biotech fostering innovation, ethical solutions to overcome challenges
GLOBAL and India's biotechnology industry plays a pivotal role in driving research, fostering innovation, and developing ethical solutions to address the complex challenges in drug development.
2 min |
November 13, 2025
Chronicle Pharmabiz
DGFT seeks feedback on application format for SCOMET export authorisation
THE Directorate General of Foreign Trade (DGFT) has invited comments and suggestions from exporters, industry associations, and other stakeholders on a proposed single-format application form for obtaining authorisation to export SCOMET items (Special Chemicals, Organisms, Materials, Equipment and Technologies).
1 min |
November 13, 2025
Chronicle Pharmabiz
AICDF launches campaign against illegal drug marketers
THE All India Chemists and Distributors Federation (AICDF) has launched a campaign to root out 'Black Sheep' marketing houses operating illegally and promoting unregistered brands across the country.
2 min |
November 13, 2025
Chronicle Pharmabiz
Haryana DCA cracks down on illegal drug sales
ACTING decisively under the ongoing Nasha Mukti Bharat Abhiyan' and explicit directions from FDA Commissioner Manoj Kumar, the drug control administration (DCA) in Haryana executed a major, coordinated inspection drive in Sirsa district on November 3.
1 min |
November 13, 2025
Chronicle Pharmabiz
Telangana DCA cracks down on illegal sale of mephentermine
THE Drugs Control Administration (DCA) in Telangana has cracked down on the illegal sale of the potent cardiac stimulant, mephentermine sulphate injection, following a raid in Namalagundu in Secunderabad.
2 min |
November 13, 2025
Chronicle Pharmabiz
Goa DFDA issues directives to 1,017 retail pharmacies to report ADRS
In a major boost towards patient safety, the Goa Directorate of Food and Drugs Administration (DFDA) has issued directives to all the 1,017 licensed retail pharmacies in the state to implement reporting of Adverse Drug Reactions (ADRs) through a QR code recently introduced by the Indian Pharmacopoeia Commission (IPC).
1 min |
November 13, 2025
Chronicle Pharmabiz
ShardaCare Healthcity opens Stroke Clinic with Rehabilitation
SHARDACARE Healthcity, a leading multispecialty hospital in North India, opened a dedicated Stroke Clinic and Comprehensive Stroke Rehabilitation Programme to enhance recovery and improve long-term outcomes for survivors.
2 min |
November 13, 2025
Chronicle Pharmabiz
Omega Hospitals acquires Cytecare Hospitals
MORGAN Stanley PE backed Hyderabad-based Omega Hospitals has acquired Cytecare Hospitals, a leading cancer care hospital in Bengaluru.
1 min |
November 13, 2025
Chronicle Pharmabiz
Indian pharmaceutical market records healthy 5-year CAGR of over 10%
THE Indian Pharmaceutical Market (IPM) has demonstrated remarkable resilience and growth momentum, recording a robust five-year Compound Annual Growth Rate (CAGR) of approximately 10.02 per cent for the period ending September 2025.
1 min |
November 13, 2025
Chronicle Pharmabiz
Sunshine by LISSUN impacts 10,000+ kids
LISSUN, one of India’s leading mental health platforms, has announced that its specialized child development and therapy division, Sunshine by LISSUN, has touched the lives of more than 10,000 children in just two years since its inception.
1 min |
November 13, 2025
Chronicle Pharmabiz
Indian Spinal Injuries Centre evolves into a multispeciality hospital
MARKING three decades of pioneering excellence, the Indian Spinal Injuries Centre (ISIC) - India's foremost institution dedicated to spinal disorders and rooted in the legacy of its founder, Major H.P.S. Ahluwalia - announced the launch of its new identity, heralding a bold transformation into the ISIC Multispeciality Hospital.
2 min |
November 13, 2025
Chronicle Pharmabiz
MvPI reviews 47,614 devices associated to adverse event cases
THE Materiovigilanc Programme of Indi (MVPI), under the aegi of the Indian Pharmaco poeia Commission (IPC), ha received and reviewed 47,61 medical device associated ad verse event cases until September 2025 since its inception in 2015.
1 min |
November 13, 2025
Chronicle Pharmabiz
US FDA to speed up biosimilars' development
THE US Food and Drug Administration (FDA) announced significant action to make it faster and less costly to develop biosimilar medicines, which are lower-cost “generic” alternatives to biologic drugs that treat serious and chronic diseases.
1 min |
November 13, 2025
Chronicle Pharmabiz
'Indian drug regulators should show zero tolerance on quality of drugs'
INDIAN drug regulatory authorities should show zero tolerance on quality of drugs as patient safety is non-negotiable, said Dr.BR Jagashetty, special resource officer, Karnataka FDA, former National Adviser (Drugs Control) to MOHFW & CDSCO and former Karnataka State Drugs Controller.
1 min |
November 13, 2025
Chronicle Pharmabiz
Omission of phytochemistry in UG Dravyaguna curriculum
PHYTOCHEMISTRY has been once an integral part of the undergraduate syllabus by Central Council of Indian Medicine.
4 min |
November 13, 2025
Chronicle Pharmabiz
IPC to develop quality standards for anti-TB medicines
THE Indian Pharmacopoeia Commission (IPC) will be developing monographs or quality standards for the three anti-tuberculosis (TB) medicines based on the recommendations of a collaborative stakeholder meet of IPC with the Government of India's apex public policy think tank NITI Aayog and the Central TB Division (CTD).
2 min |
November 13, 2025
Chronicle Pharmabiz
Pharmexcil plans global delegations for FY 25-26
IN a major push to enhance India's pharmaceutical exports, the Pharmaceuticals Export Promotion Council of India (Pharmexcil) has announced an extensive schedule of business delegations for the financial year 2025-26.
1 min |
November 13, 2025
Chronicle Pharmabiz
Health Ministry brings changes in NDCT Rules
THE Union health ministry has brought in changes to the draft amendment it issued in August, related to the BA/BE study of new drug or investigational new drug and the process of its application, to reframe the requirement of the sample size for the studies.
1 min |